ABCC3‐1767G/A polymorphism was not associated with patients with hepatocellular carcinoma (OR = 0.85, 95% CI: 0.42–1.74) (Fukuda & Kawahara, 2010). This evidence concerns the gene ABCC3 and hepatocellular carcinoma.